Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8121 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8012 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7919 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7919 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7911 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7853 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7803 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8312 |
Approved |
0.747 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.747 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7455 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7396 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7366 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7366 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7326 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7251 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7208 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7202 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD37 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7162 |
Intermediate Similarity |
NPD5126 |
Approved |
0.716 |
Intermediate Similarity |
NPD4966 |
Approved |
0.716 |
Intermediate Similarity |
NPD4965 |
Approved |
0.716 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7119 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7118 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7102 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7098 |
Intermediate Similarity |
NPD8462 |
Phase 1 |
0.7093 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7073 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7073 |
Intermediate Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7031 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6986 |
Remote Similarity |
NPD5951 |
Approved |
0.6983 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6982 |
Remote Similarity |
NPD1934 |
Approved |
0.6979 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7801 |
Approved |
0.6957 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6954 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6919 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6799 |
Approved |
0.6905 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6895 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD5404 |
Approved |
0.6894 |
Remote Similarity |
NPD5406 |
Approved |
0.6894 |
Remote Similarity |
NPD5405 |
Approved |
0.6894 |
Remote Similarity |
NPD5408 |
Approved |
0.6889 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD5403 |
Approved |
0.6875 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6872 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD5401 |
Approved |
0.6867 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD3882 |
Suspended |
0.6855 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6852 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6842 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6833 |
Remote Similarity |
NPD6764 |
Approved |
0.6833 |
Remote Similarity |
NPD6765 |
Approved |
0.6829 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6806 |
Remote Similarity |
NPD2182 |
Approved |
0.6803 |
Remote Similarity |
NPD6010 |
Discontinued |
0.6788 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6744 |
Remote Similarity |
NPD2801 |
Approved |
0.6737 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6733 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6733 |
Remote Similarity |
NPD7610 |
Discontinued |
0.673 |
Remote Similarity |
NPD7714 |
Approved |
0.673 |
Remote Similarity |
NPD7715 |
Approved |
0.6728 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6728 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6723 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6713 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6707 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD2796 |
Approved |
0.6687 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6685 |
Remote Similarity |
NPD6784 |
Approved |
0.6685 |
Remote Similarity |
NPD6785 |
Approved |
0.6667 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6667 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7319 |
Approved |
0.6667 |
Remote Similarity |
NPD5711 |
Approved |
0.6667 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD5710 |
Approved |
0.6646 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6646 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD8513 |
Phase 3 |
0.6645 |
Remote Similarity |
NPD8516 |
Approved |
0.6645 |
Remote Similarity |
NPD8517 |
Approved |
0.6645 |
Remote Similarity |
NPD8515 |
Approved |
0.6627 |
Remote Similarity |
NPD3750 |
Approved |
0.6626 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6626 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6626 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6625 |
Remote Similarity |
NPD6663 |
Approved |
0.6625
|
Remote Similarity |
NPD7713 |
Phase 3 |